Literature DB >> 8134166

Stable-isotope dilution analysis of D- and L-2-hydroxyglutaric acid: application to the detection and prenatal diagnosis of D- and L-2-hydroxyglutaric acidemias.

K M Gibson1, H J ten Brink, D S Schor, R M Kok, A H Bootsma, G F Hoffmann, C Jakobs.   

Abstract

A stable-isotope dilution assay has been developed for quantitation of D- and L-2-hydroxyglutaric acids in physiologic fluids. D- and L-2-hydroxyglutaric acids are separated as the O-acetyl-di-(D)-2-butyl esters. The method uses D,L-[3,3,4,4-2H4]-2-hydroxyglutaric acid as internal standard with ammonia chemical ionization, selected ion monitoring gas chromatography-mass spectrometry. For 13 patients with L-2-hydroxyglutaric aciduria, the concentrations of L-2-hydroxyglutaric acid were urine, 1283 +/- 676 mmol/mol creatinine (range, 332-2742; n = 12 patients); plasma, 47 +/- 13 mumol/L (range, 27-62; n = 8); cerebrospinal fluid, 62 +/- 30 mumol/L (range, 34-100; n = 6). In a child with D-2-hydroxyglutaric aciduria, the levels of D-2-hydroxyglutaric acid were urine, 1565 +/- 847 mmol/mol creatinine (range, 729-2668; n = 4); plasma, 61 +/- 14 mumol/L (range, 46-73; n = 3); cerebrospinal fluid, 15 and 25 mumol/L (n = 2). Control concentrations of D- and L-2-hydroxyglutaric acids were (D:L): urine (n = 18), 6.0 +/- 3.6 mmol/mol creatinine (range, 2.8-17): 6.0 +/- 5.4 (range, 1.3-19); plasma (n = 10), 0.7 +/- 0.2 mumol/L (range, 0.3-0.9): 0.6 +/- 0.2 (range, 0.5-1.0); cerebrospinal fluid (n = 10), 0.1 +/- 0.1 mumol/L (range, 0.07-0.3): 0.7 +/- 0.6 (range, 0.3-2.3). Investigation of control amniotic fluid (n = 10) revealed the following values (D:L): 1.2 +/- 0.4 mumol/L (range, 0.6-1.8): 4.0 +/- 0.7 (range, 3.1-5.2), suggesting the feasibility of prenatal diagnosis in families at risk.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8134166     DOI: 10.1203/00006450-199309000-00007

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  36 in total

1.  D-2-hydroxyglutaric aciduria: further clinical delineation.

Authors:  M S van der Knaap; C Jakobs; G F Hoffmann; M Duran; A C Muntau; S Schweitzer; R I Kelley; F Parrot-Roulaud; J Amiel; P De Lonlay; D Rabier; O Eeg-Olofsson
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

2.  Assessment of an electron-impact GC-MS method for organic acids and glycine conjugates in amniotic fluid.

Authors:  A Kumps; E Vamos; Y Mardens; M Abramowicz; J Genin; P Duez
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

3.  Clinical, biochemical, magnetic resonance imaging (MRI) and proton magnetic resonance spectroscopy (1H MRS) findings in a fourth case of combined D- and L-2 hydroxyglutaric aciduria.

Authors:  M-H Read; C Bonamy; D Laloum; F Belloy; J M Constans; B Guillois; M-L Kottler; N M Verhoeven; C Jakobs
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

4.  Kinetic characterization of human hydroxyacid-oxoacid transhydrogenase: relevance to D-2-hydroxyglutaric and gamma-hydroxybutyric acidurias.

Authors:  E A Struys; N M Verhoeven; H J Ten Brink; W V Wickenhagen; K M Gibson; C Jakobs
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 5.  Metabolomic signature of brain cancer.

Authors:  Renu Pandey; Laura Caflisch; Alessia Lodi; Andrew J Brenner; Stefano Tiziani
Journal:  Mol Carcinog       Date:  2017-07-17       Impact factor: 4.784

6.  D-2-hydroxyglutaric aciduria: evidence of clinical and biochemical heterogeneity.

Authors:  L Wagner; G F Hoffmann; C Jakobs
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

7.  Quantification of D- and L-2-Hydroxyglutarate in Drosophila melanogaster Tissue Samples Using Gas Chromatography-Mass Spectrometry.

Authors:  Hongde Li; Jason M Tennessen
Journal:  Methods Mol Biol       Date:  2019

8.  L-2-hydroxyglutaric aciduria: characterisation of the molecular defect in a spontaneous canine model.

Authors:  Jacques Penderis; Jacqui Calvin; Carley Abramson; Cornelis Jakobs; Louise Pettitt; Matthew M Binns; Nanda M Verhoeven; Eamonn O'Driscoll; Simon R Platt; Cathryn S Mellersh
Journal:  J Med Genet       Date:  2007-05       Impact factor: 6.318

9.  Measurement of D: -2-hydroxyglutarate dehydrogenase activity in cell homogenates derived from D: -2-hydroxyglutaric aciduria patients.

Authors:  W V Wickenhagen; G S Salomons; K M Gibson; C Jakobs; E A Struys
Journal:  J Inherit Metab Dis       Date:  2009-03-13       Impact factor: 4.982

10.  Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development.

Authors:  Erwin E W Jansen; Eduard Struys; Cornelis Jakobs; Elizabeth Hager; O Carter Snead; K Michael Gibson
Journal:  BMC Dev Biol       Date:  2008-11-28       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.